IL147408A0 - Composition for the prevention of muscle fatigue a skeletal muscle adaptation to strenuous exercise - Google Patents

Composition for the prevention of muscle fatigue a skeletal muscle adaptation to strenuous exercise

Info

Publication number
IL147408A0
IL147408A0 IL14740800A IL14740800A IL147408A0 IL 147408 A0 IL147408 A0 IL 147408A0 IL 14740800 A IL14740800 A IL 14740800A IL 14740800 A IL14740800 A IL 14740800A IL 147408 A0 IL147408 A0 IL 147408A0
Authority
IL
Israel
Prior art keywords
prevention
composition
muscle
adaptation
strenuous exercise
Prior art date
Application number
IL14740800A
Other languages
English (en)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of IL147408A0 publication Critical patent/IL147408A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
IL14740800A 1999-07-23 2000-07-21 Composition for the prevention of muscle fatigue a skeletal muscle adaptation to strenuous exercise IL147408A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000467A IT1306173B1 (it) 1999-07-23 1999-07-23 Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
PCT/IT2000/000308 WO2001006873A1 (en) 1999-07-23 2000-07-21 Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise

Publications (1)

Publication Number Publication Date
IL147408A0 true IL147408A0 (en) 2002-08-14

Family

ID=11406897

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14740800A IL147408A0 (en) 1999-07-23 2000-07-21 Composition for the prevention of muscle fatigue a skeletal muscle adaptation to strenuous exercise

Country Status (21)

Country Link
US (1) US6602512B1 (no)
EP (1) EP1196046B1 (no)
AR (1) AR024820A1 (no)
AT (1) ATE263496T1 (no)
AU (1) AU778647B2 (no)
CA (1) CA2377128C (no)
CZ (1) CZ20023A3 (no)
DE (1) DE60009704T2 (no)
DK (1) DK1196046T3 (no)
ES (1) ES2216931T3 (no)
HU (1) HU228838B1 (no)
IL (1) IL147408A0 (no)
IT (1) IT1306173B1 (no)
MX (1) MXPA02000780A (no)
NO (1) NO20020337L (no)
PL (1) PL204743B1 (no)
PT (1) PT1196046E (no)
SK (1) SK942002A3 (no)
TN (1) TNSN00161A1 (no)
TR (1) TR200200179T2 (no)
WO (1) WO2001006873A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
US7449451B2 (en) * 2001-08-29 2008-11-11 Premier Micronutrient Corporation Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks
US6849613B2 (en) 2001-08-29 2005-02-01 Kedar N. Prasad Multiple antioxidant micronutrients
DE10160485A1 (de) * 2001-12-08 2003-10-02 Degussa Verwendung von Kreatin und/oder einem seiner physiologisch geeigneten Derivate zur Prävention oder Linderung von nicht krankheitsbedingten Beeinträchtigungen und/oder Störungen der Muskelfunktion
DE102004009962A1 (de) * 2004-03-01 2005-09-22 Degussa Ag Verwendung von Guanidin-Verbindungen als physiologisches Stärkungsmittel in Form von Nahrungsergänzungsmitteln, Futtermittelzusätzen, in kosmetischen Zubereitungen und als Pflanzenstärkungsmittel
WO2006034586A1 (en) * 2004-09-29 2006-04-06 Aplodan Formulations Ltd. Nutritional composition for promoting muscle performance and acting as hydrogen (h+) blocker
WO2007006135A1 (en) * 2005-07-07 2007-01-18 H3 Formulations Ltd. Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells
GB0606864D0 (en) * 2006-04-05 2006-05-17 Univ Nottingham Increades fatty acid oxidation
EP2061473A4 (en) * 2006-08-30 2009-11-11 Aplodan Formulations Ltd INCREASE IN THE AVAILABILITY OF ATP BY INHIBITING CREATINE KINASE LEAKAGE (CK) RESULTING FROM INTENSE EXERCISE
WO2008025115A1 (en) * 2006-08-30 2008-03-06 Aplodan Formulations Ltd. Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions
US7375097B2 (en) * 2006-08-30 2008-05-20 Aplodan Formulations Ltd. Increasing ATP availability by inhibition of creatine kinase (CK) leakage resulting from high-intensity exercise
US7368441B2 (en) * 2006-08-30 2008-05-06 Aplodan Formulations Ltd. Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions
US20100124587A1 (en) * 2008-11-17 2010-05-20 Heuer Marvin A Creatine-containing vitamin and mineral composition
US20110105786A1 (en) * 2009-11-02 2011-05-05 Tianjin Tiancheng Pharmaceutical Co., Ltd. Creatinol o-phosphate and synthesis method thereof
US8865660B2 (en) 2010-12-10 2014-10-21 Broady Health Sciences, Llc Method of treating neurogenic overactive bladder in a mammal or method of treating non-psychological stress-related bladder dysfunction in a female mammal by administering at least on jasmonate
ES2949825T3 (es) * 2014-06-12 2023-10-03 Lonza Greenwood Llc Método para disminuir el daño muscular esquelético y/o el estrés oxidativo en mamíferos
US10499682B2 (en) 2014-08-25 2019-12-10 New Age Beverage Corporation Micronutrient formulation in electronic cigarettes
WO2017075289A1 (en) 2015-10-27 2017-05-04 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
CA3008033A1 (en) 2015-12-18 2017-06-22 Lonza, Inc. Method and composition for increasing muscle protein synthesis and/or functional strength in mammals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IT1124697B (it) * 1979-10-26 1986-05-14 Simes Derivati di creatinolo o-fosfato ad azione terapeutica,procedimento per la sua preparazione e relativ-e composizioni farmaceutiche
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
IT1291127B1 (it) 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
JP2002510604A (ja) * 1998-04-02 2002-04-09 アビセナ グループ， インク． クレアチン化合物及び第二物質の組み合わせを含む組成
ES2146555B1 (es) * 1999-01-22 2001-03-01 Helsint S A L Empleo de formulaciones a base de fracciones hidrosolubles de phlebodium decumanum (exply-37) y/o polypodium leucotomos como complemento nutricional en la prevencion y reversion del sindrome de sobresfuerzo fisico.

Also Published As

Publication number Publication date
WO2001006873A1 (en) 2001-02-01
PL204743B1 (pl) 2010-02-26
HUP0202298A2 (en) 2002-10-28
AU778647B2 (en) 2004-12-16
ITRM990467A1 (it) 2001-01-23
SK942002A3 (en) 2002-05-09
CZ20023A3 (cs) 2002-06-12
IT1306173B1 (it) 2001-05-30
PL352683A1 (en) 2003-09-08
ITRM990467A0 (it) 1999-07-23
ES2216931T3 (es) 2004-11-01
NO20020337L (no) 2002-03-22
TNSN00161A1 (fr) 2005-11-10
EP1196046A1 (en) 2002-04-17
DK1196046T3 (da) 2004-08-02
HU228838B1 (en) 2013-06-28
DE60009704T2 (de) 2005-04-14
CA2377128A1 (en) 2001-02-01
US6602512B1 (en) 2003-08-05
DE60009704D1 (de) 2004-05-13
ATE263496T1 (de) 2004-04-15
AR024820A1 (es) 2002-10-23
EP1196046B1 (en) 2004-04-07
MXPA02000780A (es) 2002-08-20
CA2377128C (en) 2009-09-22
PT1196046E (pt) 2004-08-31
HUP0202298A3 (en) 2005-07-28
NO20020337D0 (no) 2002-01-22
AU6468700A (en) 2001-02-13
TR200200179T2 (tr) 2002-06-21

Similar Documents

Publication Publication Date Title
IL147408A0 (en) Composition for the prevention of muscle fatigue a skeletal muscle adaptation to strenuous exercise
EP1005330A4 (en) METHODS AND COMPOSITIONS FOR TARGETING COMPOUNDS TO MUSCLES
TW330417U (en) Improved wrist exerciser
GB2312172B (en) Decorative handles for implements such as sports racquets
GB9724813D0 (en) Reducing muscle fatigue
TW420019U (en) Adjustable grip exerciser
GB2314782B (en) Muscle exerciser
GB9715534D0 (en) Rowing exerciser
GB9904667D0 (en) Hand or foot pedalled exerciser
AU5591700A (en) Exercise grips attached to shoes
GB9919682D0 (en) Improvements relating to muscle toner pads
GB2360000B (en) Improvements relating to exercising devices
TW353378U (en) Sport & training machine for foot muscle
TW340388U (en) Addition 1 to the hip exerciser
TW368880U (en) Improved wrist strenghtening exercise equipment
GB9722565D0 (en) Respiratory muscle trainer
GB0114513D0 (en) Muscle exerciser
TW381476U (en) Structure of standing plate for coordinating the muscle tension of foot
TW408609U (en) Improvement of treading exerciser
TW361271U (en) Exercising ski for muscle exercising of waist
TW367840U (en) Palm muscle massager with grip-force training
GB9414711D0 (en) Improvements to muscle training devices
TW376768U (en) Structure of the grip exerciser
TW327813U (en) Hip training exerciser
TW333040U (en) Ocular muscle training machine structure